Equities

Zymeworks Inc

Zymeworks Inc

Actions
  • Price (EUR)11.50
  • Today's Change0.20 / 1.77%
  • Shares traded200.00
  • 1 Year change+83.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments374492253
Total Receivables, Net193316
Total Inventory------
Prepaid expenses191920
Other current assets, total------
Total current assets413545288
Property, plant & equipment, net384850
Goodwill, net121212
Intangibles, net252621
Long term investments820.890.89
Note receivable - long term------
Other long term assets------
Total assets581649389
LIABILITIES
Accounts payable6.217.865.17
Accrued expenses418157
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.03--0.02
Other current liabilities, total8.746.679.97
Total current liabilities569672
Total long term debt0.090.120.10
Total debt0.120.120.12
Deferred income tax3.301.791.57
Minority interest------
Other liabilities, total575867
Total liabilities116156140
SHAREHOLDERS EQUITY
Common stock1,007907741
Additional paid-in capital142152198
Retained earnings (accumulated deficit)(677)(559)(683)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(6.6)(6.66)(6.66)
Total equity465493249
Total liabilities & shareholders' equity581649389
Total common shares outstanding716447
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.